⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7356709 | 1.00 | — | — | |
| SCHEMBL5306179 | 0.80 | CYP2D6 (0.32) | — | |
| SCHEMBL30803975 | 0.80 | CYP2D6 (0.32) | — | |
| SCHEMBL5903240 | 0.80 | ALDH1A1 (0.52) | — | |
| SCHEMBL10836044 | 0.78 | CYP2D6 (0.35) | — | |
| SCHEMBL108460 | 0.76 | — | — | |
| SCHEMBL29512257 | 0.76 | — | — | |
| SCHEMBL230823 | 0.75 | P2RX7 (0.33) | — | |
| SCHEMBL12925942 | 0.75 | MAOA (0.36) | — | |
| SCHEMBL5300518 | 0.75 | KDM4E (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598916-A1 | HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF | Amgen Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20240366614-A1 | ARYLQUINAZOLINES | MERCK PATENT GMBH (DE) | 2024-11-07 | — | — | US | disclosed |
| WO-2024076672-A1 | HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF | AMGEN INC. (US) | 2024-04-11 | — | — | WO | disclosed |
| US-20220117970-A1 | ARYLQUINAZOLINES | MERCK PATENT GMBH (DE) | 2022-04-21 | — | — | US | disclosed |